Company Results


All ShareCafe Content

EZZ Life Science targets US expansion

EZZ Life Science Holdings (ASX:EZZ) has set its sights on the lucrative US market after securing regulatory clearance from the United States Food and Drug Administration (FDA) for nine of its products in the food category. This milestone marks a significant leap forward for the genomic life science company as it aims to capitalize on the robust demand for healthcare products in the US.

Read More

ASX down 0.57% near noon: ResMed suffers significant losses

Shares on Australia's S&P/ASX 200 Index declined at the opening bell due to concerns over potential inflation acceleration prompting the Reserve Bank to consider raising interest rates, contrasting global easing trends. Healthcare stocks, notably ResMed, suffered significant losses following disappointing trial results. Additionally, weakened commodity prices, including a decline in Singapore iron ore futures, impacted mining shares like BHP.

Read More